SEC Comment Letter for WINDTREE THERAPEUTICS (WINT) — Jul 18, 2019
WINDTREE THERAPEUTICS INC /DE/ (WINT, WINTW) (CIK 0000946486)
Date: July 18, 2019 · CIK: 0000946486 · Accession: 0000000000-19-011271
AI Filing Summary & Sentiment
File numbers found in text: 000-26422
Letter
July 18, 2019 Craig E. Fraser President and Chief Executive Officer Windtree Therapeutics, Inc. 2600 Kelly Road, Suite 100 Warrington, Pennsylvania 18976-3622 Re:Windtree Therapeutics, Inc. Preliminary Information Statement on Schedule 14C Filed June 24, 2019 File No. 000-26422 Dear Mr. Fraser: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Brian Lee - Dentons US LLP
Show Raw Text
July 18, 2019
Craig E. Fraser
President and Chief Executive Officer
Windtree Therapeutics, Inc.
2600 Kelly Road, Suite 100
Warrington, Pennsylvania 18976-3622
Re:Windtree Therapeutics, Inc.
Preliminary Information Statement on Schedule 14C
Filed June 24, 2019
File No. 000-26422
Dear Mr. Fraser:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Brian Lee - Dentons US LLP